A Guide to the New RSV Prevention

Aside from COVID-19 and the flu, RSV causes more respiratory illnesses, hospitalizations, and ICU stays than any other virus. Newborns are especially at risk. According to the CDC, it’s “the most common cause of bronchiolitis and pneumonia in children younger than 1 year of age.” Infants less than 6 months are most likely to get seriously ill from RSV and require hospitalization.

A new vaccine has just been introduced, limited to pregnant women and people age 60 and up. If you qualify, please talk to your doctor about getting the vaccine, as it will not only protect you from contracting the virus, but also prevent you from spreading it to others. For pregnant mothers, there is extra good news - by vaccinating yourself, you will be passing on protection to your infant for the first 6 months of their life.

While there is no vaccine for children available. there is a new Monoclonal Antibody (Nirsevimab, also called Beyfortus), which provides passive immunity to newborns who are most vulnerable to the virus. This antibody is administered just like a vaccine, and will provide protection for up to 5 months. It is available for all infants under 8 months old during RSV season.

Call today to schedule an appointment or ask how to protect your child against respiratory illnesses.